Quantcast

Latest Pluripotency Stories

2010-12-09 20:12:38

Remarkable progress in understanding how stem cell biology works has been reported by a team of leading scientists, directed by experts at UC Santa Barbara. Their research has been published in the journal Cell Stem Cell. Stem cell biology is making waves around the world with great hope for the eventual repair of parts of the body. While many scientists see these breakthroughs as viable, there are hurdles that must be overcome, including the worrisome potential for introducing cancer when...

003486282c9153eca00d225c1a69a9581
2010-12-08 13:30:34

A small monkey that had been paralyzed from the neck down because of a spinal injury has been partially restored by stem cells, Japanese researchers said. "It is the world's first case in which a small-size primate recovered from a spinal injury using stem cells," professor Hideyuki Okano of Tokyo's Keio University told AFP. He said the team injected so-called induced pluripotent stem (iPS) cells into paralyzed marmoset. According to Kyodo News, the team planted four types of genes into...

2010-12-01 08:30:00

MADISON, Wis., Dec. 1, 2010 /PRNewswire/ -- Cellular Dynamics International's (CDI) iCell(TM) Cardiomyocytes have been recognized among the top five winners of the "Top 10 Innovations of 2010" by The Scientist magazine. CDI is the world's largest manufacturer of human cardiomyocytes and is the only company in the world to produce human cardiomyocytes derived from human induced pluripotent stem cells (iPSCs). The company's iCell Cardiomyocytes product was selected due to its demonstration...

2010-11-15 13:48:05

Growing human embryonic stem cells in the lab is no small feat. Culturing the finicky, shape-shifting cells is labor intensive and, in some ways, more art than exact science. Now, however, a team of researchers at the University of Wisconsin-Madison reports the development of a fully defined culture system that promises a more uniform and, for cells destined for therapy, safer product. Writing this week (Nov. 14) in the journal Nature Methods, a team led by Laura Kiessling, a UW-Madison...

53ad6fefff9ca5621fbe136401517c931
2010-11-11 14:50:00

Using induced pluripotent stem cells from patients with Rett syndrome, scientists at the University of California, San Diego School of Medicine have created functional neurons that provide the first human cellular model for studying the development of autism spectrum disorder (ASD) and could be used as a tool for drug screening, diagnosis and personalized treatment. The research, led by Alysson R. Muotri, PhD, assistant professor of pediatrics, will be published in the November 12 issue of...

2010-11-04 07:00:00

MADISON, Wis., Nov. 4, 2010 /PRNewswire/ -- Cellular Dynamics International, Inc. (CDI) announced today that it has been awarded a total of $977,915 for investments in four qualifying therapeutic discovery projects. CDI, the world's largest producer of human tissue cells for drug discovery and safety, will use the grant money to advance the development of its programs in hepatocytes, neurons, endothelial cells, and creation of multiple induced pluripotent stem cell (iPSC) lines. All of...

2010-10-28 15:16:39

A team of researchers from Boston University's Center for Regenerative Medicine and the Pulmonary Center have generated 100 new lines of human induced pluripotent stem cells (iPSC) from individuals with lung diseases, including cystic fibrosis and emphysema. The new stem cell lines could possibly lead to new treatments for these debilitating diseases. The findings, which appear in the current issue of Stem Cells, demonstrate the first time lung disease-specific iPSC have been created in a...

2010-10-25 01:00:00

PARIS and KYOTO, Japan, Oct. 25 /PRNewswire/ -- Cellectis (Alternext: ALCLS), the French genome engineering specialist, and the Center for iPS Cells Research and Application (CiRA) of Kyoto University, Kyoto, Japan, have announced today that they have started a scientific collaboration to combine Cellectis' genome engineering technologies with CiRA's induced pluripotent stem cell (iPS) technology to improve the natural characteristics of iPS cells for use as cellular tools. CiRA was...

2010-10-19 12:44:26

Two research teams from the Okayama University Graduate School of Medicine (Okayama, Japan) have reported breakthrough studies in liver cell transplantation. One team found that the technical breakthrough in creating induced pluripotent stem cells (iPS) from mouse somatic cells (nonsex cells) in vitro had "implications for overcoming immunological rejection." Whereas a second team using liver cell xenotransplantation - transplanting cells of one species into another (in this case...

2010-10-18 01:00:00

PARIS and KYOTO, Japan, Oct. 18 /PRNewswire/ -- Cellectis (Alternext: ALCLS), the French genome engineering specialist, and iPS Academia Japan Inc. (Kyoto, Japan) announced today that they have signed two separate non-exclusive agreements granting Cellectis worldwide access to the induced Pluripotent Stem (iPS) cells patent portfolio arising from the work of Professor Shinya Yamanaka, MD, Ph.D., Center for iPS Cell Research and Application (CiRA) at the University of Kyoto, Japan. The...


Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related